Save Sight Institute and Keratoconus Australia have launched a comprehensive resource that provides patients with essential information on corneal collagen...
Read moreDetailsA keratoconus study out of Sydney has found the potentially quicker pulsed corneal crosslinking (CXL) protocol is likely to be...
Read moreDetailsNew research from the Save Sight Institute, The University of Sydney and the Sydney Eye Hospital has revealed the effects...
Read moreDetailsA new Israeli-based cross-sectional study has revealed a link between males with keratoconus and attention-deficit/hyperactivity disorder (ADHD). As eye-rubbing...
Read moreDetailsAt the completion of this article, the reader should be able to improve their management of keratoconus, including: Understand clinical...
Read moreDetailsThe long-term effectiveness of corneal cross-linking in keratoconus, as well as the mental health toll of the disease, the emergence...
Read moreDetailsAn Australian ophthalmology duo are streamlining keratoconus surgical procedures with their development of the CAIRS Plan tool, which they are...
Read moreDetailsAt the completion of this article, the optometrist should be able to understand their role in management of patients...
Read moreDetailsMelbourne biotech company muPharma, founded by ophthalmologist Dr Harry Unger and Mr Mark Unger, has developed an investigational device that...
Read moreDetailsCorneal collagen cross-linking revolutionised treatment for keratoconus patients when it was introduced in the late 1990s, but it was a...
Read moreDetails
Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited